News Headlines Article

Johnson & Johnson to pay $3.4B to buy Auris Health
San Francisco Business Times

Johnson & Johnson has agreed to buy robotic surgery firm Auris Health for $3.4 billion in cash.

The Redwood City company’s robotic camera helps doctors see inside the body, including in the lungs. It was recently valued at about $2.1 billion after raising $220 million in funding in November.

The deal gives Johnson & Johnson (NYSE:JNJ) an entry into robotics and builds on a partnership with South San Francisco-based Verily Life Sciences. It is developing the Verb surgical platform — combining robotics with advanced visualization and data analytics — with the Alphabet Inc. life science unit.